Skip to main content

Innovation in Tuberculosis

Objective

The objective of INNOVA4TB is to enhance and strengthen the collaborative research among sectors and to form a network aimed to perform high-quality and translational research in the field of diagnosis and management of tuberculosis (TB). The consortium is constituted by 12 institutions from 8 countries that combine complementary and synergic expertise: clinical management (hospitals), basic science and new technologies (academic institutions), and industrial development and entrepreneurship culture (SMEs). The exchanges between the institutions allow the participants to progress in their career perspectives.
TB is one of the major infectious diseases worldwide, and the emergence and spread of drug resistant cases is a public health threat. However, the conventional methods used for diagnosis and drug-susceptibility testing are not enough for controlling the disease. In addition, all TB patients, independently of their age, gender, severity of the disease and type of responsible strain, follow the same treatment duration (up to 20 months in drug resistant cases), which often leads to high frequency of adverse events, suboptimal adherence to treatment, and poor outcome. A transition from programmatic to personalized management of TB is needed. Our proposal will develop innovative technologies and approaches in order to improve the individual risk assessment for TB development, to rapidly diagnose active TB, to detect the drug susceptibility of the strain, to design tailor-made therapies, and to use biomarkers to guide and individualize the duration of antimicrobial therapy. This is of great importance for improving the quality of life of patients and ensuring treatment success, as well as for economic reasons for the healthcare system.

Field of science

  • /medical and health sciences/health sciences/public and environmental health/epidemics prevention
  • /medical and health sciences/health sciences/public and environmental health
  • /medical and health sciences/health sciences/infectious disease
  • /medical and health sciences/clinical medicine/pneumology/tuberculosis

Call for proposal

H2020-MSCA-RISE-2018
See other projects for this call

Funding Scheme

MSCA-RISE - Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE)

Coordinator

INSTITUT DE INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL
Address
Ctra De Canyet S/n
08916 Badalona Barcelona
Spain
Activity type
Research Organisations
EU contribution
€ 220 800

Participants (14)

CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P.
Spain
EU contribution
€ 50 600
Address
Calle Monforte De Lemos 5
28029 Madrid
Activity type
Research Organisations
UMEA UNIVERSITET
Sweden
EU contribution
€ 92 000
Address
Universitetomradet
901 87 Umea
Activity type
Higher or Secondary Education Establishments
ODESSA NATIONAL I.I. MECHNIKOV UNIVERSITY
Ukraine
EU contribution
€ 101 200
Address
Dvoryanska St; 2
65026 Odessa
Activity type
Higher or Secondary Education Establishments
"INSTITUTIA MEDICO-SANITARA PUBLICA - INSTITUTUL DE FTIZIOPNEUMOLOGIE ""CHIRIL DRAGANIUC"""
Moldova
EU contribution
€ 73 600
Address
Strada Virnav C 13
2025 Chisinau
Activity type
Research Organisations
KOMUNALNE NEKOMERSHCHYNE PRIDPRYEMSTVO ODESKYY OBLASNYY TSENTR SOTSIALNO ZNACHUCHYKH KHVOROB ODESKOI OBLASNOY RADY
Ukraine
EU contribution
€ 211 600
Address
Belinskogo Str.9/11
65014 Odesa
Activity type
Other
VINNYTSIA NATIONAL M.I. PYROGOV MEDICAL UNIVERSITY
Ukraine
EU contribution
€ 78 200
Address
Pirogov Street 56
21018 Vinnitsa
Activity type
Higher or Secondary Education Establishments
SERVICIOS CLINICOS SA
Spain
EU contribution
€ 55 200
Address
Calle Garcia Y Marino 4
08022 Barcelona
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Genome Identification Diagnostics GmbH
Germany
EU contribution
€ 23 000
Address
Ebinger Str. 4
72479 Strassberg
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EMPE DIAGNOSTICS AB
Sweden
EU contribution
€ 23 000
Address
Karolinska Istitute Science Park Nobels Vag 16
171 65 Stockholm
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
MAGRITEK GMBH
Germany
EU contribution
€ 23 000
Address
Philipsstrasse 8
52068 Aachen
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
UNIVERSIDAD DE ZARAGOZA
Spain
EU contribution
€ 32 200
Address
Calle Pedro Cerbuna 12
50009 Zaragoza
Activity type
Higher or Secondary Education Establishments
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES- CIC biomaGUNE
Spain
EU contribution
€ 18 400
Address
Paseo Miramon 182, Parque Tecnologico De San Sebastian Edificio Empresarial C
20009 San Sebastian
Activity type
Research Organisations
INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD
Spain
EU contribution
€ 18 400
Address
Avenida San Juan Bosco 13
50009 Zaragoza
Activity type
Research Organisations
UNIVERSIDAD POLITECNICA DE MADRID
Spain
EU contribution
€ 18 400
Address
Calle Ramiro De Maeztu 7 Edificio Rectorado
28040 Madrid
Activity type
Higher or Secondary Education Establishments

Partners (1)

UNIVERSIDAD DE LA FRONTERA
Chile
Address
Avda Francisco Salazar 01145
Temuco
Activity type
Higher or Secondary Education Establishments